|
⚲
|
| Keyboard |
| Jeffrey Leiden | |
|---|---|
| Firm | |
| Address | 51 Sleeper Street Suite 800 Boston, MA 02210 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Odyssey Therapeutics Inc | 021-565797 | Director | 214.0 M of 214.0 M |
||
| Odyssey Therapeutics Inc | 021-499898 | Director | 117.2 M of 121.1 M |
||
| Odyssey Therapeutics Inc | 021-462964 | Director | 168.0 M of 174.9 M |
||
| Casana Care Inc | 021-430526 | Director | 40.0 M of 40.0 M |
||
| Biolex Therapeutics Inc | 021-170312 | Director | 2.4 M of 3.2 M |
||
| Variation Biotechnologies US Inc | 021-162994 | Director | 3.5 M of 3.5 M |
||
| Variation Biotechnologies US Inc | 021-162993 | Director | 4.3 M of 4.3 M |
||
| Biolex Therapeutics Inc | 021-161034 | Director | 5.9 M of 6.7 M |
||
| TYRX Pharma Inc | 021-151474 | Director | 23.1 M of 25.2 M |
||
| Catabasis Pharmaceuticals Inc | 021-140570 | Director | 7.7 M of 39.7 M |
||
| Lycera Corp | 021-96985 | Director | 33.9 M of 38.9 M |
||